METRIOPHARM
MetrioPharm AG is a pharmaceutical development company developing drugs for chronic inflammatory diseases such as psoriasis, arthritis, and multiple sclerosis. Such chronic diseases pose the greatest individual health risk. The goal of MetrioPharm AG is to make the therapy of chronic inflammatory diseases more effective and more tolerable. They hope to achieve a healthspan expansion for patients: They want to stop the progression of chronic inflammatory diseases as early as possible and significantly prolong the healthy lifespan of millions of people. MetrioPharm AG was founded in 2007 and is headquartered in Zurich with research facilities in Berlin.
METRIOPHARM
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.metriopharm.com
Total Employee:
11+
Status:
Active
Contact:
+41 (44) 515 21 97
Total Funding:
20 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Apache
Similar Organizations
Purple Biotech
Purple Biotech is an innovative biopharmaceutical drug development company.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.metriopharm.com Semrush global rank: 5.85 M Semrush visits lastest month: 1.42 K
- Host name: dd23328.kasserver.com
- IP address: 85.13.151.76
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "MetrioPharm"
MetrioPharm AG – Contact
Contact Contact Contact MetrioPharm AG Europaallee 41 8004 Zurich Phone: +41 44 552 7190 MetrioPharm Deutschland GmbH Franklinstrasse 28/29 10587 Berlin You can also reach us …See details»
MetrioPharm AG – Pipeline/Overview
MetrioPharm's pipeline of small-molecule immune modulators is based on the common MP1000 compound platform.See details»
MetrioPharm - LinkedIn
MetrioPharm AG is a Swiss biotech company developing first-in-class auto-regulated immune modulators targeting the pathologically dysregulated …See details»
MetrioPharm - Crunchbase Company Profile & Funding
MetrioPharm AG is a pharmaceutical development company developing drugs …See details»
MetrioPharm AG – Management and Board
About us Management and Board Management and Board MetrioPharm AG Thomas Christély – Chief Executive Officer (CEO) Substantial collaborations and licensing agreements with major …See details»
MetrioPharm - Company Profile | BizStanding
Description:MetrioPharm AG is a Swiss pharmaceutical R&D company with headquarters in Zurich, Switzerland and a R&D Center in Berlin, Germany. At MetrioPharm, we focus on the …See details»
MetrioPharm Invest-Newsletter QII 2025
The 19th Annual General Meeting took place on June 16, 2025, in Zurich. With the annual report, the management and Board of Directors of MetrioPharm AG provided an overview of the …See details»
Four new members elected to the Board of Directors of …
Apr 17, 2025 Four new members elected to the Board of Directors of MetrioPharm AGRegister for Free to get streaming real-time quotes, interactive charts, live options flow, and more.See details»
Four new members elected to the Board of Directors of …
Apr 17, 2025 Four new members elected to the Board of Directors of MetrioPharm AGTrade like a pro: Leverage real-time discussions and market-moving ideas to outperform.See details»
MetrioPharm 2025 Company Profile: Valuation, …
Information on acquisition, funding, investors, and executives for MetrioPharm. Use the PitchBook Platform to explore the full profile.See details»
Dr. Stephan Rietiker elected as new Chairman of the Board of ...
Zurich, April 23, 2025 - MetrioPharm AG, a pharmaceutical company developing drugs for inflammatory and infectious diseases, announced today that the new Board of Directors …See details»
MetrioPharm AG – Swiss Biotech
MetrioPharm AG, a clinical stage biopharmaceutical development company based in Zurich with a subsidiary in Berlin, Germany, has developed a platform of small molecule drug candidates …See details»
Dr. Stephan Rietiker elected as new Chairman of the Board of …
Zurich, April 23, 2025 – MetrioPharm AG, a pharmaceutical company developing drugs for inflammatory and infectious diseases, announced today that the new Board of Directors …See details»
Four new members elected to the Board of Directors of …
Zurich, April 17, 2025 – MetrioPharm AG, a biotech company developing drugs for inflammatory and infectious diseases, announced today that four new... read full storySee details»
MetrioPharm: Contact Details and Business Profile - RocketReach
MetrioPharm is a Pharmaceutical Manufacturing, Biotechnology, and Science and Engineering company_reader located in Zürich, Zurich with 19 employees. Find top employees, contact …See details»
Dr. Stephan Rietiker elected as new Chairman of the Board of ...
Apr 23, 2025 Dr. Rietiker has considerable experience in the life sciences industry, including leadership positions in global pharmaceutical and medical device companies, and has …See details»
MetrioPharm Investor Relations News QII 2024
MetrioPharm AG began conducting preclinical studies in the indication Duchenne muscular dystrophy in 2022. MetrioPharm was supported by co-funding from the patient organization …See details»
Four new members elected to the Board of Directors of …
Apr 17, 2025 Their appointment was initiated by the outgoing board of directors. The four new members will bring many years of experience in the biotech and pharmaceutical industry, …See details»
MetrioPharm AG - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore MetrioPharm AG with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 7 news, Disease Domain:Immune System Diseases, Nervous System …See details»
MetrioPharm Investor-Update QIV 2024
In order to prepare this process at an early stage, MetrioPharm has intensified its already very good contact with the DMD community and met with patient organizations, physicians, and the …See details»